Dumont & Blake Investment Advisors LLC Oramed Pharmaceuticals Inc. Transaction History

Dumont & Blake Investment Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$8.19 - $13.89 $67,567 - $114,592	-8,250 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$12.98 - $29.75 $2,596 - $5,950	200 Added 2.48%	8,250 $118,000
Q3 2021 Nov 02, 2021	BUY	$12.13 - $23.82 $97,646 - $191,751	8,050 New	8,050 $177,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $91.2M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Dumont & Blake Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Dumont & Blake Investment Advisors LLC with notifications on news.